Literature DB >> 12236303

Hepatitis B vaccination among high-risk adolescents and adults--San Diego, California, 1998-2001.

.   

Abstract

The national strategy to eliminate hepatitis B virus (HBV) transmission is based on 1) screening all pregnant women for hepatitis B surface antigen and post-exposure vaccination of infants of infected mothers; 2) vaccinating all infants as part of the childhood vaccination schedule; 3) vaccinating children and adolescents not vaccinated previously; and 4) vaccinating adolescents and adults in groups at increased risk for infection. These strategies have been implemented successfully in the United States except for the vaccination of adults and older adolescents at high risk. This report describes the initial findings of a hepatitis B vaccination program for potentially high-risk adolescents and adults conducted in areas of San Diego County, California. The findings indicate that high rates of hepatitis B vaccination can be achieved in clinics and programs that serve persons at high risk for HBV infection through the integration of hepatitis B vaccination into routine preventive health-care services. Improved efforts to vaccinate adolescents and adults at increased risk for HBV infection are critical to reduce disease incidence and prevent chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236303

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  19 in total

1.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Balancing the childhood immunization program with the urgent needs for adult hepatitis B immunization.

Authors:  Lance E Rodewald; Litjen Tan
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility.

Authors:  Amy J Khan; Edgar P Simard; William A Bower; Heather L Wurtzel; Marina Khristova; Karla D Wagner; Kathryn E Arnold; Omana V Nainan; Madeleine LaMarre; Beth P Bell
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

Review 5.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

6.  Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.

Authors:  Huai Wang; Binyu Cai; Delong Rao; Min Liu; Yabin Li; Xiaofeng Liang; Fuqiang Cui; Guomin Zhang; Fuzhen Wang; Xinghuo Pang; Li Nie; Qian Qiu; Jiang Wu; Liqiu Li; Fang Huang; Wei Zhang
Journal:  Hum Vaccin Immunother       Date:  2016-11       Impact factor: 3.452

7.  Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007.

Authors:  F Ladak; A Gjelsvik; E Feller; S R Rosenthal; S Rosenthal; B T Montague
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

8.  The effect of vaccinated children on increased hepatitis B immunization among high-risk adults.

Authors:  Deepika L Koya; Elizabeth G Hill; Paul M Darden
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

9.  Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.

Authors:  Peng-Jun Lu; Kathy K Byrd; Trudy V Murphy
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

10.  Economic benefits of hepatitis B vaccination at sexually transmitted disease clinics in the U.S.

Authors:  M'Kiaira K Miriti; Kaafee Billah; Cindy Weinbaum; Julie Subiadur; Richard Zimmerman; Paula Murray; Robert Gunn; Joanna Buffington
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.